文献速递糖尿病

用于1型糖尿病的HLA II类四聚体检测技术的验证与实用性:一项多中心研究

Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

本研究对用于检测HLA-DRA-DRB1*04:01限制性胰岛抗原特异性T细胞的四聚体 assay 进行技术验证,在单中心和多中心使用克隆掺入标本和1型糖尿病患者重复样本检测,目标变异系数小于30%。结果显示流感特异性T细胞在单中心平均CV为6%和11%,多中心为20%和31%;胰岛特异性T细胞单中心平均CV为14%和23%,多中心为23%和41%。探索性横断面样本集发现T细胞频率和表型与病程、性别及自身抗体相关,且大部分胰岛特异性T细胞呈现初始表型。

要点

  • 四聚体 assay 在单中心和多中心检测中均显示可重复性,但多中心变异系数高于单中心。
  • 胰岛特异性T细胞测量在多中心测试中平均CV为23%和41%,未完全达到目标CV小于30%。
  • 横断面分析发现T细胞频率和表型与病程、性别和自身抗体存在关联。

核心结论

  • 该四聚体 assay 具有可重复性,可用于表征胰岛特异性T细胞并识别T细胞指标与临床特征之间的关联。

研究设计与样本

  • 技术验证研究,采用单中心和多中心测试,使用克隆掺入标本和1型糖尿病患者重复样本,目标变异系数小于30%。
  • 探索性横断面样本集纳入24例1型糖尿病患者以评估 assay 的实用性。

主要发现

  • 流感特异性T细胞测量在单中心测试中克隆掺入标本平均CV为6%、1型糖尿病样本为11%,多中心测试分别为20%和31%。
  • 胰岛特异性T细胞测量在单中心测试中平均CV为14%和23%,多中心测试分别为23%和41%。
  • 横断面研究发现T细胞频率和表型与病程、性别和自身抗体相关。
  • 大部分胰岛特异性T细胞呈现初始表型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Validated assays to measure autoantigen-specific T-cell frequency and phenotypes are needed for assessing the risk of developing diabetes, monitoring disease progression, evaluating responses to treatment, and personalizing antigen-based therapies. OBJECTIVE: Toward this end, we performed a technical validation of a tetramer assay for HLA-DRA-DRB1*04:01, a class II allele that is strongly associated with susceptibility to type 1 diabetes (T1D). METHODS: HLA-DRA-DRB1*04:01-restricted T cells specific for immunodominant epitopes from islet cell antigens GAD65, IGRP, preproinsulin, and ZnT8, and a reference influenza epitope, were enumerated and phenotyped in a single staining tube with a tetramer assay. Single and multicenter testing was performed, using a clone-spiked specimen and replicate samples from T1D patients, with a target coefficient of variation (CV) less than 30%. The same assay was applied to an exploratory cross-sectional sample set with 24 T1D patients to evaluate the utility of the assay. RESULTS: Influenza-specific T-cell measurements had mean CVs of 6% for the clone-spiked specimen and 11% for T1D samples in single-center testing, and 20% and 31%, respectively, for multicenter testing. Islet-specific T-cell measurements in these same samples had mean CVs of 14% and 23% for single-center and 23% and 41% for multicenter testing. The cross-sectional study identified relationships between T-cell frequencies and phenotype and disease duration, sex, and autoantibodies. A large fraction of the islet-specific T cells exhibited a naive phenotype. CONCLUSION: Our results demonstrate that the assay is reproducible and useful to characterize islet-specific T cells and identify correlations between T-cell measures and clinical traits.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ettinger RA, Buitinga M, Vandamme C, et al. Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study. J Clin Endocrinol Metab. 2023. PMID: 37474341. doi:10.1210/clinem/dgad434

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。